Sotera Health Company (NASDAQ:SHC) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Sotera Health Company (NASDAQ:SHC) have been given an average recommendation of “Moderate Buy” by the ten ratings firms that are covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $20.3333.

Several research analysts recently issued reports on SHC shares. Citigroup increased their target price on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a research note on Tuesday, February 24th. Weiss Ratings lowered shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday, May 21st. Wall Street Zen lowered shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Barclays cut their target price on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Finally, Zacks Research lowered shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 30th.

Sotera Health Stock Down 0.7%

Shares of NASDAQ SHC opened at $15.64 on Friday. The firm has a market cap of $4.46 billion, a PE ratio of 38.15 and a beta of 1.82. Sotera Health has a 12-month low of $10.80 and a 12-month high of $19.85. The company’s fifty day simple moving average is $15.20 and its 200 day simple moving average is $16.38. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.01. The business had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. Sotera Health’s revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, sell-side analysts forecast that Sotera Health will post 0.86 earnings per share for the current fiscal year.

Insider Buying and Selling at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the firm’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 15.36% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. Arizona State Retirement System lifted its stake in shares of Sotera Health by 1.4% in the third quarter. Arizona State Retirement System now owns 46,183 shares of the company’s stock valued at $726,000 after buying an additional 621 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of Sotera Health by 10.8% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,204 shares of the company’s stock valued at $127,000 after purchasing an additional 705 shares during the last quarter. Strs Ohio raised its holdings in shares of Sotera Health by 17.4% in the fourth quarter. Strs Ohio now owns 4,895 shares of the company’s stock valued at $86,000 after purchasing an additional 727 shares during the last quarter. Federated Hermes Inc. raised its holdings in shares of Sotera Health by 6.0% in the fourth quarter. Federated Hermes Inc. now owns 16,676 shares of the company’s stock valued at $294,000 after purchasing an additional 944 shares during the last quarter. Finally, First Citizens Bank & Trust Co. raised its holdings in shares of Sotera Health by 1.5% in the fourth quarter. First Citizens Bank & Trust Co. now owns 66,266 shares of the company’s stock valued at $1,169,000 after purchasing an additional 970 shares during the last quarter. 91.03% of the stock is owned by institutional investors.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.